AI assistant
Sending…
Actinium Pharmaceuticals, Inc. — Director's Dealing 2018
Jun 16, 2018
34570_dirs_2018-06-15_f6764f57-d5ea-423f-a2c1-5695f2f6595b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Actinium Pharmaceuticals, Inc. (ATNM)
CIK: 0001388320
Period of Report: 2018-06-15
Reporting Person: O'Loughlin Steve (Principal Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-06-15 | Common Stock | P | 12000 | $0.50 | Acquired | 25500 | Direct |
More from Actinium Pharmaceuticals, Inc.
Delisting Announcement
2026
May 29
Annual Report
2026
Mar 30
Declaration of Voting Results & Voting Rights Announcements
2026
Mar 26
Board/Management Information
2026
Feb 13
Declaration of Voting Results & Voting Rights Announcements
2025
Nov 26
Interim / Quarterly Report
2025
Nov 14
Annual Report
2025
Nov 5
Proxy Solicitation & Information Statement
2025
Nov 5
Director's Dealing
2025
Aug 20
Interim / Quarterly Report
2025
Aug 8